Codexis has appointed Peter Strumph, Senior Vice President and Business Head of Pharmaceuticals, as interim CEO following the surprise decision by Alan Shaw to step down. The company said Shaw resigned to pursue other interests, but will will continue to serve as a special advisor to the Board of Directors.
San Francisco Business Journal
Monday, 20 February 2012
Codexis appoints interim CEO
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment